Type 1 Diabetes Mellitus (T1DM)
Metabolic
Prevalence
200.0 / 100K
Incidence
22.0 / 100K/yr
2 drugs in development·1 company·0 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| up421 | Sana Biotechnology, Inc. (SANA) |
Preclinical(1)
| Drug | Company |
|---|---|
| sc451 | Sana Biotechnology, Inc. (SANA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Type 1 Diabetes Mellitus (T1DM)?
BioSniper tracks 2 drugs in development for Type 1 Diabetes Mellitus (T1DM) across 1 company.
What is the prevalence of Type 1 Diabetes Mellitus (T1DM)?
The estimated prevalence of Type 1 Diabetes Mellitus (T1DM) is approximately 200.0 per 100,000 population.
Deep-dive into Type 1 Diabetes Mellitus (T1DM)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis